日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

A charitable access program for patients with lysosomal storage disorders in underserved communities worldwide

一项面向全球服务不足社区溶酶体贮积症患者的慈善援助项目

Mehta, Atul; Ramaswami, Uma; Muenzer, Joseph; Giugliani, Roberto; Ullrich, Kurt; Collin-Histed, Tanya; Panahloo, Zoya; Wellhoefer, Hartmann; Frader, Joel

A response to Germain, et al. The effect of enzyme replacement therapy on clinical outcomes in male patients with Fabry disease: A systematic literature review by a European panel of experts. Mol Genet Metab Rep Feb 6 2019

对 Germain 等人发表的题为“酶替代疗法对法布里病男性患者临床结局的影响:欧洲专家组系统性文献综述”的文章的回应。Mol Genet Metab Rep,2019 年 2 月 6 日。

Gurevich, Andrey; Schenk, Jӧrn; Wellhoefer, Hartmann; Kalampoki, Vasiliki

Evaluating enzyme replacement therapies for Anderson-Fabry disease: commentary on a recent report

评估安德森-法布里病酶替代疗法:对近期一份报告的评论

Giugliani, Roberto; Westwood, Stephanie; Wellhoefer, Hartmann; Schenk, Jörn; Gurevich, Andrey; Kampmann, Christoph

Continuous separation of protein loaded nanoparticles by simulated moving bed chromatography

利用模拟移动床色谱法连续分离负载蛋白质的纳米颗粒

Satzer, Peter; Wellhoefer, Martin; Jungbauer, Alois